Binaphthyl-based dicationic peptoids with therapeutic potential. - Wikidata - awgldk - TriplyDB

Binaphthyl-based dicationic peptoids with therapeutic potential.

Binaphthyl-based dicationic peptoids with therapeutic potential.

http://www.wikidata.org/entity/Q43219153

about

Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection De novo design and synthesis of ultra-short peptidomimetic antibiotics having dual antimicrobial and anti-inflammatory activities.Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands.Binaphthyl-1,2,3-triazole peptidomimetics with activity against Clostridium difficile and other pathogenic bacteria.Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides.Binaphthyl-anchored antibacterial tripeptide derivatives with hydrophobic C-terminal amino acid variations.Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold.From multiply active natural product to candidate drug? Antibacterial (and other) minor groove binders for DNA.l-Lysine based lipidated biphenyls as agents with anti-biofilm and anti-inflammatory properties that also inhibit intracellular bacteria.Synthesis and antimicrobial activity of binaphthyl-based, functionalized oxazole and thiazole peptidomimetics.Short antimicrobial lipo-α/γ-AA hybrid peptides.Amphipathic guanidine-embedded glyoxamide-based peptidomimetics as novel antibacterial agents and biofilm disruptors.Synthesis and biological evaluation of N-naphthoyl-phenylglyoxamide-based small molecular antimicrobial peptide mimics as novel antimicrobial agents and biofilm inhibitors.

P2860

Q28551610-A84181C0-2218-4754-A94C-5EE4C75AD2F7 Q31145703-9623A422-BAEF-427A-8E96-E429BC09A626 Q34594159-E7E49C9C-D438-4BEA-ABB4-31C6C14B46B3 Q35611260-6648F09D-2D78-4821-AD8E-948D2E7666D9 Q35781198-F3C6545D-C64F-4B17-ABCA-23774BADAAD9 Q36281200-ACD6C15E-7EA5-4FEE-AD47-52E8AB465A88 Q37692425-224AD7D9-D7A5-4D1B-AC2A-6E467D0DC0E2 Q38014897-42273239-FD98-4788-A32D-1757F6E56E93 Q40136867-D4DBDE3C-F2BC-4629-8231-05500AC42D05 Q41010306-EE233107-6EEC-4405-A6F5-69D106D0D2C9 Q42182872-AC160DBA-09DF-4E87-9721-61655FB45878 Q48231448-E18A21EF-8666-4D2F-81AA-5E9600EB0010 Q50869052-6283F110-4C3D-4822-89EC-04C02D2D0FE7

P2860

Binaphthyl-based dicationic peptoids with therapeutic potential.

http://www.wikidata.org/entity/Q43219153

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Binaphthyl-based dicationic peptoids with therapeutic potential.

@en

Binaphthyl-based dicationic peptoids with therapeutic potential.

@nl

type

label

Binaphthyl-based dicationic peptoids with therapeutic potential.

@en

Binaphthyl-based dicationic peptoids with therapeutic potential.

@nl

prefLabel

Binaphthyl-based dicationic peptoids with therapeutic potential.

@en

Binaphthyl-based dicationic peptoids with therapeutic potential.

@nl

P1433

Q43219153-4FB25072-832D-45AB-8C3E-9BCCA48DC1AD

P1476

Q43219153-3A366C3F-E661-445D-9034-696A588730AD

P2093

Q43219153-0B4C4CAD-4878-485B-B593-E5BE7E369ABF

Q43219153-0D665869-70C7-4233-B2F8-FB47A05895B1

Q43219153-167FDE83-3BB3-490F-A69E-E5522F7A84DF

Q43219153-2B010310-8F99-4E88-A719-548A01C3A7BC

Q43219153-320BB00D-2DD9-461B-85E9-E0412BB37F2F

Q43219153-3E825DD2-AC6C-407B-AC5E-FD35C1489992

Q43219153-57884C91-97D1-4ED6-AE79-354B9933A56B

Q43219153-5DB1182A-DB5F-43CF-B8F1-6BCFD8BECA8F

Q43219153-698649A4-95AD-4502-B4FA-51854C78A737

Q43219153-6B0C365A-3CCF-4DB9-9E46-47CBE26D76E2

P2860

Q43219153-0A12D840-79AD-4407-BBDD-21A413921046

Q43219153-1BB3DBC4-4173-44B6-9E18-15075C5A6969

Q43219153-1DF179AE-0948-4852-97F6-C0A32ABE86F5

Q43219153-20F7587A-D1FB-43F7-A018-E790F84A5A73

Q43219153-278730C5-FDF7-41F0-BDE9-2536B8957C78

Q43219153-2C07AB98-4A1C-477C-94B0-243A5D403985

Q43219153-2FA102CA-351B-45BF-BFCF-723D06EF93BD

Q43219153-392BD805-20C7-4E13-B85D-5AB1F42D102A

Q43219153-3ABAE80A-B8A9-4E14-8945-C82099BE3A6A

Q43219153-3B32A42E-8733-4AB7-BF3A-F68DA3340129

P304

Q43219153-59ED574A-E8EB-47DD-8131-EB8658C5FB9B

P31

Q43219153-AFB03088-C40D-4FF9-80B7-D23D42F320E0

P356

Q43219153-89789DFB-B748-4601-9DC9-F1DE1AF332C1

P407

Q43219153-010F8DED-81DF-4725-B5E4-BB6C609730D1

P433

Q43219153-69DB9B72-05C5-4A1F-8946-58D0756F695E

P478

Q43219153-F66843EC-C550-483B-A4EC-9CFF15DDB025

P50

Q43219153-01757899-7F24-4492-A50E-C97925B4B1C9

Q43219153-98AB1549-6C65-4449-9976-4DDCFAA67151

Q43219153-D854A533-E115-4E27-90B5-6BAA141B2354

P577

Q43219153-CD0C0F5F-F4B7-44C4-8BAF-0738C256614D

P698

Q43219153-37097A71-46C8-489D-B3C9-0348713733E2

P356

P1433

Angewandte Chemie International Edition

P1476

Binaphthyl-based dicationic peptoids with therapeutic potential

@en

P2093

Adam S Howe

http://www.w3.org/2001/XMLSchema#string

Adel Garas

http://www.w3.org/2001/XMLSchema#string

Andrea McCracken

http://www.w3.org/2001/XMLSchema#string

David I Rhodes

http://www.w3.org/2001/XMLSchema#string

Dean Baylis

http://www.w3.org/2001/XMLSchema#string

Dharshini Jeevarajah

http://www.w3.org/2001/XMLSchema#string

Dorothy M David

http://www.w3.org/2001/XMLSchema#string

Douglas J Biedenbach

http://www.w3.org/2001/XMLSchema#string

John B Bremner

http://www.w3.org/2001/XMLSchema#string

John Deadman

http://www.w3.org/2001/XMLSchema#string

P2860

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus

Antibacterial natural products in medicinal chemistry--exodus or revival?

Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria.

Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.

High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.

Glycopeptide and lipoglycopeptide antibiotics.

Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.

Glycopeptides in clinical development: pharmacological profile and clinical perspectives.

Peptide antimicrobial agents.

Late stage antibacterial drugs in the clinical pipeline.

P304

537-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANIE.200904392

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20014083

http://www.w3.org/2001/XMLSchema#string